MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mdc3.70554

Медицинская библиотека · Movement disorders clinical practice · 2026

Resolution of Levodopa/Dopa-Decarboxylase Inhibitor-Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature.

Hintner Romana, Eberhardt Franziska, Kofler Manuela, Eigentler Andreas, Djamshidian Atbin, Krismer Florian, Hittmair Anton, Zoller Heinz, Ellinger Valentina, Heim Beatrice, Seppi Klaus

СтатьяКлинический случайОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Microscopic colitis (MC) typically presents with chronic, non-bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa-decarboxylase inhibitor (LDDCI) therapy.

CASES: We present two people with Parkinson's disease (PD; PwP) who developed MC on LDDCI therapy. Symptoms of MC resolved following the transition from oral LDDCI therapy to continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI).

LITERATURE REVIEW: A review of the literature identified 21 reported cases of parkinsonism patients who developed MC during LDDCI therapy across three articles. Diarrheal symptoms improved after treatment modification, either by switching the LDDCI formulation or by discontinuing the therapy.

CONCLUSION

In PwP presenting with LDDCI-associated MC, CSFLI represents an effective alternative that maintains dopaminergic efficacy while bypassing the gastrointestinal tract. Early recognition and timely switching to parenteral levodopa formulations may prevent prolonged symptoms and complications of MC in PwP. Microscopic colitis, a rare adverse effect of LDDCI therapy, may resolve completely with CSFLI.

Для цитирования: Hintner Romana, Eberhardt Franziska, Kofler Manuela, Eigentler Andreas, Djamshidian Atbin, Krismer Florian, Hittmair Anton, Zoller Heinz, Ellinger Valentina, Heim Beatrice, Seppi Klaus. Resolution of Levodopa/Dopa-Decarboxylase Inhibitor-Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature.. Movement disorders clinical practice. 2026. DOI: 10.1002/mdc3.70554.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.